Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q2, 26 TTM Selling/general/admin expenses 427 M406 M433 M529 M332 M 1.72 B Research & development ————— — Operating income 378 M486 M-175 M425 M367 M 995 M Non-Operating Income, Total -4 M12 M22 M13 M58 M 89 M Interest expense, net of interest capitalized 89 M91 M90 M2 M62 M 243 M Non-Operating Income, excl. Interest Expenses -89 M0-90 M-2 M-62 M -243 M Unusual income/expense -4 M12 M22 M13 M58 M 89 M Pretax income 272 M442 M-249 M343 M349 M 715 M Equity in earnings -13 M-11 M-6 M-8 M-17 M -44 M Taxes 81 M45 M103 M225 M52 M 461 M Non-controlling/minority interest 3 M5 M3 M10 M0 16 M After tax other income/expense ————— — Net income before discontinued operations 129 M393 M-355 M138 M298 M 210 M Discontinued operations 60 M———-50 M — Net income 189 M393 M-355 M138 M248 M 220 M Dilution adjustment ————— — Preferred dividends ————— — Diluted net income available to common stockholders 189 M393 M-355 M138 M248 M 220 M Basic earnings per share (Basic EPS) 0.891.8-1.630.641.17 1.07 Diluted earnings per share (Diluted EPS) 0.881.8-1.630.641.17 1.06 Average basic shares outstanding 212.91 M217.73 M217.41 M214.89 M211.56 M — Diluted shares outstanding 213.8 M218.11 M217.41 M216.14 M212.1 M — EBITDA 630 M739 M76 M-1.01 B504 M 195 M EBIT 378 M486 M-175 M-1.42 B367 M -853 M Cost of revenue 4.17 B4.21 B4.19 B4.19 B2.5 B 15.05 B Other cost of goods sold ————— — Depreciation & amortization (cash flow) 252 M253 M251 M408 M137 M 1.05 B